We employ cutting-edge gene editing and synthetic biology techniques to manipulate cells at the cancer-immune interface, using models that faithfully mimic the complexities of cancer and the immune system.

We track these manipulations by combining classical immunological methods with integrated multi-omic strategies. To validate the clinical significance of our findings, we study samples graciously contributed by patients.